A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide.
Article in Psychopharmacology Bulletin (March 2024)
The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.
Article in Psychopharmacology Bulletin (March 2024)
Article in Journal of Clinical Psychology (February 2024)
Article in JAMA Dermatology (January 2024)